Diagenode Revenue and Competitors

Buranda, AU

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Diagenode's estimated annual revenue is currently $24.2M per year.(i)
  • Diagenode's estimated revenue per employee is $155,000

Employee Data

  • Diagenode has 156 Employees.(i)
  • Diagenode grew their employee count by 2% last year.

Diagenode's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Administration & HRReveal Email/Phone
3
Head Global Marketing OperationsReveal Email/Phone
4
RA/QA OfficerReveal Email/Phone
5
QC OfficerReveal Email/Phone
6
Head BioinformaticsReveal Email/Phone
7
Regulatory Affairs OfficerReveal Email/Phone
8
Creative and Digital Marketing OfficerReveal Email/Phone
9
R&D ManagerReveal Email/Phone
10
Product Manager - Epigenomic ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$128M8266%N/AN/A
#2
$22.3M144-1%N/AN/A
Add Company

What Is Diagenode?

Diagenode is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays based in Liege, Belgium and NJ, USA. The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services. ► EPIGENETICS RESEARCH : Epigenetics is playing a revolutionary role in life sciences research. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available. ► MOLECULAR DIAGNOSTICS : Diagenode offers amplification and quantification methods for DNA targets of human infectious disease to meet the fast-paced growth of human disease diagnostics. We also provide guidance to diagnostics companies to develop epigenetics-based diagnostics. Our products are designed to make diagnostic assays simpler, faster, and of highest quality. Our kits are CE-marked and certified ISO 9001 and ISO 13485. Innovating Epigenetics Solutions, Human Infectious diseases Molecular Diagnostics, Custom Epigenetic Research Services, Real-Time qPCR detection

keywords:N/A

N/A

Total Funding

156

Number of Employees

$24.2M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Diagenode News

2022-04-20 - Epigenetics Instrument Market Size, Outlook And Forecast ...

Illumina, Thermo Fisher, Diagenode, QIAGEN, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, PerkinElmer, Bio-Rad.

2022-04-20 - Epigenetic Market 2022 by Major Players: Illumina,Diagenode ...

Illumina, Diagenode, Merck & Co, Qiagen, Thermo Fisher Scientific, Abcam, Roche Diagnostics, New England Biolabs, Sigma-Aldrich,...

2022-04-20 - RNA Sequencing Services Market Size 2022-2029| Key ...

Thermo Fisher; Diagenode; BGI; Active Motif; CD Genomics; Illumina; GENEWIZ; Exiqon; LC Sciences; Novogene; Qiagen; Arraystar; CeGaT GmbH; Phalanx...

2021-01-07 - Diagenode launches innovative solution for small RNA-sequencing compatible with MGI’s DNBSEQ™ sequencers

This powerful solution combines our best-in-class RNA library preparation with MGI’s high-quality, cost-effective, DNA nanoballs sequencing solution, creating a unified platform to support high quality small RNA sequencing. DENVILLE, N.J. and LIEGE, Belgium (PRWEB) January 07, 2021 Diagenode, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$50M2846%N/A
#2
N/A343-3%N/A
#3
$72.4M4679%N/A